Efficacy of glue-lipiodol mixture for the control of hemoptysis: comparison with non-glue embolic materials

초록

PURPOSE: To evaluate the efficacy of transcatheter embolization with glue-lipiodol mixture for the control of hemoptysis compared to that with coil, particle, or gelfoam. METHOD/MATERIALS: Transcatheter embolization of bronchial, intercostal, or systemic arteries was performed in thirty-four patients who suffered from massive hemoptysis with acute onset. Among them, 24 cases underwent embolization with glue-lipiodol mixture (glue group) and 10 underwent with coil (n=6), particle (n=2), or gelfoam (n=2) (non-glue group). Rate and cause of recurrence of hemoptysis were retrospectively analyzed between above two groups. Cost for embolization for one artery and for one session was compared between above two groups. RESULTS: In glue group, hemoptysis recurred in six cases (6/24; 25%) within 6 months. In non-glue group, hemoptysis recurred in five cases (5/10; 50%). Among them, one case (1/10; 10%) recurred within 7 days and the others (4/10; 40%) within 6 months. The causes of recurrence were systemic collateral supply (n=5) and hemorrhage from a different artery which had not underwent transcatheter embolization (n=1) in glue group, whereas systemic collateral supply distal to embolized point (n=1) and recanalization of embolized artery (n=4) in non-glue group. Average cost for embolization of one artery was 251.7 US dollars in glue group and 388.1 US dollars in non-glue group. Average cost for one case was 520.9 US dollars in glue group and 865.0 US dollars in non-glue group. CONCLUSIONS: Transcatheter embolization with glue-lipiodol mixture is more effective in controlling hemoptysis than that with non-glue embolic materials.